<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-1991</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИНФАРКТ МИОКАРДА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MYOCARDIAL INFARCTION</subject></subj-group></article-categories><title-group><article-title>Ремоделирование левого желудочка у больных с обратимой ишемической дисфункцией до и после реваскуляризации миокарда</article-title><trans-title-group xml:lang="en"><trans-title>Left ventricular remodelling in patients with reversible ischemic dysfunction before and after myocardial revascularization</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маматкулов</surname><given-names>Х. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mamatkulov</surname><given-names>Kh. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>докторант</p><p>Ташкент, Тел.: +998903257999 </p></bio><bio xml:lang="en"><p>Tashkent</p></bio><email xlink:type="simple">mamatkulov-1972@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аляви</surname><given-names>А. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Alyavi</surname><given-names>A. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>руководитель отдела неотложной кардиологии РНЦЭМП;</p><p>директор Республиканского специализированного научно-практического медицинского центра терапии и медицинской реабилитации Ташкент </p></bio><bio xml:lang="en"><p>Tashkent</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кенжаев</surname><given-names>М. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Kenzhaev</surname><given-names>M. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>с.н.с.</p><p>Ташкент </p></bio><bio xml:lang="en"><p>Tashkent</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алимов</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Alimov</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>интервенционный кардиолог</p><p>Ташкент </p></bio><bio xml:lang="en"><p>Tashkent</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кенжаев</surname><given-names>С. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Kenzhaev</surname><given-names>S. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант</p><p>Ташкент </p></bio><bio xml:lang="en"><p>Tashkent</p></bio><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ташкентская медицинская академия</institution></aff><aff xml:lang="en"><institution>Tashkent Medical Academy</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Республиканский научный центр экстренной медицинской помощи;&#13;
Республиканский специализированный научно-практический медицинский центр терапии и медицинской реабилитации</institution></aff><aff xml:lang="en"><institution>Republican Scientific Centre of Emergency Medicine</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Республиканский научный центр экстренной медицинской помощи</institution></aff><aff xml:lang="en"><institution>Republican Scientific Centre of Emergency Medicine</institution></aff></aff-alternatives><aff xml:lang="ru" id="aff-4"><institution>Республиканский специализированный научно-практический медицинский центр терапии и медицинской реабилитации</institution><country>Uzbekistan</country></aff><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>01</day><month>01</month><year>1970</year></pub-date><volume>10</volume><issue>7</issue><fpage>28</fpage><lpage>32</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Маматкулов Х.А., Аляви А.Л., Кенжаев М.Л., Алимов Д.А., Кенжаев С.Р., 1970</copyright-statement><copyright-year>1970</copyright-year><copyright-holder xml:lang="ru">Маматкулов Х.А., Аляви А.Л., Кенжаев М.Л., Алимов Д.А., Кенжаев С.Р.</copyright-holder><copyright-holder xml:lang="en">Mamatkulov K.A., Alyavi A.L., Kenzhaev M.L., Alimov D.A., Kenzhaev S.R.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/1991">https://cardiovascular.elpub.ru/jour/article/view/1991</self-uri><abstract><p>Цель. Изучить динамику показателей ремоделирования ЛЖ у больных, перенесших инфаркт миокарда (ИМ) с обратимой ишемической дисфункцией до и после реваскуляризации. Материал и методы. В исследование отобрали 69 больных, перенесших ИМ. Всем больным проводили двухмерную эхокардиографию (ЭхоКГ) на 1 сут. после госпитализации и через 1 мес. после реваскуляризации. На 3-4 сут. лечения после стабилизации состояния больным выполняли стресс-ЭхоКГ с добутамином с целью определения жизнеспособного миокарда. Результаты. Было установлено: полное (n=22), I группа (гр.); частичное (n=19), II гр. Восстановление всех асинергичных сегментов или наличие аневризмы ЛЖ (n=28), III гр. У большинства пациентов во всех гр. проведена транслюминальная баллонная ангиопластика (ТЛБАП) со стентированием. Наиболее чаще консервативное лечение использовалось в III гр. Однако, несмотря на реваскуляризацию, у больных ИБС с отсутствием жизнеспособного миокарда (III-я гр.) значительно меньше возросла фракция выброса и снизился конечный систолический объем, чем у больных с жизнеспособным миокардом. Индекс сферичности, индекс относительной толщины стенок, миокардиальный стресс, были увеличены во всех гр., хотя в III гр. оно было недостоверно. После реваскуляризации установлено достоверное уменьшение показателей конечного систолического размера и тенденции к уменьшениям конечного диастолического размера ЛЖ во всех исследованных гр., но более значительное снижение этих показателей отмечено в I гр. Заключение. У больных, перенесших ИМ, при наличии жизнеспособного миокарда в зонах нарушенной сократимости ЛЖ методом выбора лечения является хирургическая реваскуляризация.</p></abstract><trans-abstract xml:lang="en"><p>Aim. To study the dynamics of left ventricular (LV) remodelling in patients with myocardial infarction (MI) and reversible ischemic dysfunction, before and after myocardial revascularization. Material and methods. The study included 69 patients after MI. All participants underwent two-dimensional echocardiography (EchoCG), within 24 hours after hospital admission and one month after revascularization. After three-four days of treatment and clinical stabilization, the patients underwent stress EchoCG with dobutamine, to assess myocardial viability. Results. Complete or partial recovery of all asynergic myocardial segments was observed in 22 (Group I) and 19 (Group II) patients, respectively, while in 28 (Group III), LV aneurysm was detected. In most patients from each group, transluminal balloon angioplasty (TLBAP) with stent implantation was performed. The proportion of conservatively treated patients was maximal in Group III. Despite revascularization, in coronary patients with impaired myocardial viability (Group III), the increase in ejection fraction and reduction in end-systolic volume was significantly lower than in patients with viable myocardium. Sphericity index, relative wall thickness index, and myocardial stress parameters were increased in each group, although this increase was non-significant in Group III. After revascularization, a significant reduction in end-systolic volume, and a tendency towards enddiastolic LV volume reduction were observed in each group, being maximal in Group I. Conclusion. In MI patients with viable myocardium in dyskineticLV zones, revascularization surgery should be considered.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>левый желудочек</kwd><kwd>ремоделирование</kwd><kwd>добутамин</kwd><kwd>инфаркт миокарда</kwd><kwd>реваскуляризация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Left ventriculum</kwd><kwd>remodelling</kwd><kwd>dobutamine</kwd><kwd>myocardial infarction</kwd><kwd>revascularization</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Беленков Ю.Н., Мареев В.Ю., Орлова Я.А. и др. Магнитнорезонансная томография в оценке ремоделирования левого желудочка у больных с сердечной недостаточностью. Кардиология 1996; 36(4): 15-22.</mixed-citation><mixed-citation xml:lang="en">Беленков Ю.Н., Мареев В.Ю., Орлова Я.А. и др. Магнитнорезонансная томография в оценке ремоделирования левого желудочка у больных с сердечной недостаточностью. Кардиология 1996; 36(4): 15-22.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Бокерия Л.А., Бузиашвили Ю.И. Чреспищеводная эхокардиография в коронарной хирургии. Издательство НЦССХ им. А.Н. Бакулева Москва 1999; 120 с.</mixed-citation><mixed-citation xml:lang="en">Бокерия Л.А., Бузиашвили Ю.И. Чреспищеводная эхокардиография в коронарной хирургии. Издательство НЦССХ им. А.Н. Бакулева Москва 1999; 120 с.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Braumgarther H, Porenta G, Lan YK, et al. Assessment of myocardial viability by dobutamine echocardiography, PET and thallium-201 SPECT: correlation with histopathology in explanated hearts. JACC 1998; 32: 1701-8.</mixed-citation><mixed-citation xml:lang="en">Braumgarther H, Porenta G, Lan YK, et al. Assessment of myocardial viability by dobutamine echocardiography, PET and thallium-201 SPECT: correlation with histopathology in explanated hearts. JACC 1998; 32: 1701-8.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Geraci E, Franzosi MG, Santoro E, et. al. Ten-year-follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction. Circulation 1998; 98: 2659-65.</mixed-citation><mixed-citation xml:lang="en">Geraci E, Franzosi MG, Santoro E, et. al. Ten-year-follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction. Circulation 1998; 98: 2659-65.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Jugdutt Bodh I. Apoptosis after reperfused myocardial infarction: Role of angiotensin II.</mixed-citation><mixed-citation xml:lang="en">Jugdutt Bodh I. Apoptosis after reperfused myocardial infarction: Role of angiotensin II.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Exper clin cardiol 2004; 9(4): 219-28.</mixed-citation><mixed-citation xml:lang="en">Exper clin cardiol 2004; 9(4): 219-28.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">La Carina G, Rahimtoola SH, Visioli O, et al. Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly in combination, for diagnosis of hibernating myocardium. Eur Heart J 2000; 21(16): 1358-67.</mixed-citation><mixed-citation xml:lang="en">La Carina G, Rahimtoola SH, Visioli O, et al. Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly in combination, for diagnosis of hibernating myocardium. Eur Heart J 2000; 21(16): 1358-67.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Marchese A, Galiuto L, Cavallari D, et al. The protective effect of coronary collateral circulation on myocardial viability: a case of acute coronary occlusion. Cardiologia (Rome, Italy) 1994; 39(5): 359-62.</mixed-citation><mixed-citation xml:lang="en">Marchese A, Galiuto L, Cavallari D, et al. The protective effect of coronary collateral circulation on myocardial viability: a case of acute coronary occlusion. Cardiologia (Rome, Italy) 1994; 39(5): 359-62.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Morgan JP, Erny RE, Allen PD, et al. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation 1990; 81 (suppl III): 111-21-32.</mixed-citation><mixed-citation xml:lang="en">Morgan JP, Erny RE, Allen PD, et al. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation 1990; 81 (suppl III): 111-21-32.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Panza JA, Laurienzo JM, Curiel RV, et al. Transesophageal dobutamine stress echocardiography for evaluation of patients with coronary artery disease. JACC 1994; 24(5): 1260-7.</mixed-citation><mixed-citation xml:lang="en">Panza JA, Laurienzo JM, Curiel RV, et al. Transesophageal dobutamine stress echocardiography for evaluation of patients with coronary artery disease. JACC 1994; 24(5): 1260-7.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Popovic MD, Bojic M, Aleksandar D, et al. Detection of significant residual stenosis of the infarct-related artery after thrombolysis by high-dose dipyridamole echocardiography test: Is it detected often enough? Сlin Cardiol 1997; 20(6): 569-72.</mixed-citation><mixed-citation xml:lang="en">Popovic MD, Bojic M, Aleksandar D, et al. Detection of significant residual stenosis of the infarct-related artery after thrombolysis by high-dose dipyridamole echocardiography test: Is it detected often enough? Сlin Cardiol 1997; 20(6): 569-72.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
